Impact of airway wall fibrosis on the efficacy of anti-asthma drugs
Grant number: 299823
Most episodes of asthma are controlled or prevented by current medications. In a small, but significant proportion of asthmatics (5-10%) symptoms persist despite the use of the best combinations of anti-asthma drugs. One of the reasons that acute episodes of asthma occur is that the airway tubes slowly change in structure. These changes involve an increase in the amount of collagen (part of the cement between cells) making the airway stiffer. In this project, we are exploring the impact of the stiffening of the airway on the way that different cells within the airway wall respond to drugs used to treat asthma. Our initial findings suggest that when the airway wall becomes stiffer with more c..View full description
Related publications (4)
Resistance of fibrogenic responses to glucocorticoid and 2-methoxyestradiol in bleomycin-induced lung fibrosis in mice
Shenna Y Langenbach, Ben J Wheaton, Darren J Fernandes, Catherine Jones, Tara E Sutherland, Bronwyn C Wraith, Trudi Harris, Michael J Schuliga, Catriona McLean, Alastair G Stewart
Bleomycin-induced lung fibrosis in mice reproduces some key features of pulmonary fibrosis in humans including alveolar inflammati..
The PPAR gamma ligand, rosiglitazone, reduces airways hyperresponsiveness in a murine model of allergen-induced inflammation
JE Ward, DJ Fernandes, CC Taylor, JV Bonacci, L Quan, AG Stewart
There is considerable interest in the role of peroxisome proliferator activated receptors (PPARs) as ligand-activated transcriptio..
Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle
T Tran, DJ Fernandes, M Schuliga, T Harris, L Landells, AG Stewart
For a subpopulation of asthmatics, symptoms persist even with high doses of glucocorticoids. Glucocorticoids reduce the levels of ..